Topics

Forecasts show branded generics will double in revenue with Asia driving growth

07:11 EST 13 Feb 2020 | Pharmafile

Branded generic drugs are expected to grow in global sales by 8% by 2029, but Europe and America will not be the regions driving this growth.

These were the findings based on a recent global analysis of branded generics carried out by the International Generics Pharmaceutical Alliance and latest reports from Future Markets Insights (FMI). It shows that China, India and Asia Pacific will lead the global branded generics market through to 2029.

read more

Original Article: Forecasts show branded generics will double in revenue with Asia driving growth

NEXT ARTICLE

More From BioPortfolio on "Forecasts show branded generics will double in revenue with Asia driving growth"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.